Biogen’s stake in Samsung Bioepis has been fully acquired by former partner Samsung Biologics, following an announcement of the deal in January.
Samsung BioLogics has completed its full acquisition of Samsung Bioepis Co., Ltd., purchasing Biogen, Inc.’s 50% -1 equity stake in the former joint venture for $2.3bn. An initial payment of $1.0bn has now been made, with the remaining $1.25bn to be paid in instalments over the next two years.
The agreement, which was announced back in January, will see Samsung Biologics make a further payment of $812.5m at the...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
